Recent Trading Context For Azenta
Azenta (AZTA) has drawn attention after recent trading left the share price at $34.09, with moves that now reflect a mixed pattern across the past week, month and past 3 months.
Recent trading has cooled after a strong run, with Azenta's share price falling 6.65% over the last day and 9.62% over the past week. However, the 3 month share price return of 29.82% and 1 year total shareholder return of 10.07% still point to momentum that contrasts with weaker 3 year and 5 year total shareholder returns.
Scan beyond Azenta and spot other potential turnaround or momentum stories by using our curated list of 20 high quality undiscovered gems , which pairs stronger fundamentals with under-the-radar pricing.
Bulls view Azenta as a discounted compound sample and multiomics platform with improving earnings power, while bears focus on recent losses and weak long-term returns. Which side does the current valuation support next?
Most Popular Narrative: 13% Undervalued
Against Azenta's last close of $34.09, the most followed narrative pegs fair value at $39.00, which, based on that framework and its discount rate of 8.06%, suggests a clear valuation gap.
The ongoing trend of life sciences digitization and automation is reflected in Azenta's improved operational execution and introduction of more automated solutions. These efficiency gains, alongside investments in R&D and product management, are associated with significant gross margin and EBITDA margin expansion, which in turn points to potential net margin improvements with increased scale.
See why 3 investors see Azenta as 13% undervalued .
Result: Fair Value of $39 (UNDERVALUED)
Still, the Azenta story can change quickly if ongoing CEO upheaval and securities investigations weigh on customer confidence or stretch management focus at a delicate point.
Find out about the key risks to this Azenta narrative .
Another View On Azenta's Valuation
The analyst narrative leans on earnings forecasts and a $39 fair value, yet the SWS DCF model presents a different picture. Based on those cash flow assumptions, Azenta at $34.09 is above an estimated value of $22.58, which indicates a potential overvaluation rather than a discount. Which framework do you consider more appropriate for your own thesis?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Azenta for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 33 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Sentiment on Azenta is split. Hesitation rarely helps your process, so review the data now, weigh the upside signals, and see the 2 key rewards
Looking For More Investment Ideas Beyond Azenta?
Do not stop with Azenta alone. Broaden your watchlist now so you are not scrambling later when fresh opportunities have already moved without you.
-
Target stability first and filter for 32 resilient stocks with low risk scores that aim to limit downside while still giving you room to participate when markets turn.
-
Prioritise financial strength and run a list of solid balance sheet and fundamentals (25 results) to spot businesses with cleaner debt profiles and sturdier fundamentals backing their share prices.
-
Hunt for mispriced potential and review the 33 high quality undervalued stocks before the rest of the market fully prices in their underlying quality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AZTA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
